Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Coleman

Showing results (41-50 of 589) with videos related to

Pageof 59
Sort By:
Current Opinion in Supportive and Palliative Care|July 26, 2011
Adjuvant therapy with bone-targeted agentsC Wilson, R E Coleman
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Malignant mixed mullerian tumours of gynaecological origin: chemosensitive but aggressive tumoursE Krishnan, R E Coleman
Bone|July 13, 2010
Advances in management of bone disease in breast cancerL Walkington, R E Coleman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Possible pitfalls with clinical imaging of indium-111 leukocytes: concise communicationR E Coleman, D Welch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Clinical PET: are we ready?R E Coleman, R D Tesar
Behaviour Research and Therapy|January 1, 1977
Processes underlying generalization through participant modeling with self-directed practiceG P Smith, R E Coleman
Cancer Treatment Reviews|August 17, 1999
The potential of melanoma antigen expression in cancer therapyA M Gillespie, R E Coleman
AJNR. American Journal of Neuroradiology|August 1, 1995
Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDSJ M Hoffman, R E Coleman
Cancer Treatment Reviews|January 1, 1993
Osteoclast inhibition for the treatment of bone metastasesR E Coleman, O P Purohit
Seminars in Nuclear Medicine|November 4, 1998
Applications of PET in lung cancerA Al-Sugair, R E Coleman
Pageof 59

Showing results (41-50 of 589) with videos related to

Sort By:
Pageof 59
Current Opinion in Supportive and Palliative Care|July 26, 2011
Adjuvant therapy with bone-targeted agentsC Wilson, R E Coleman
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Malignant mixed mullerian tumours of gynaecological origin: chemosensitive but aggressive tumoursE Krishnan, R E Coleman
Bone|July 13, 2010
Advances in management of bone disease in breast cancerL Walkington, R E Coleman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Possible pitfalls with clinical imaging of indium-111 leukocytes: concise communicationR E Coleman, D Welch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Clinical PET: are we ready?R E Coleman, R D Tesar
Behaviour Research and Therapy|January 1, 1977
Processes underlying generalization through participant modeling with self-directed practiceG P Smith, R E Coleman
Cancer Treatment Reviews|August 17, 1999
The potential of melanoma antigen expression in cancer therapyA M Gillespie, R E Coleman
AJNR. American Journal of Neuroradiology|August 1, 1995
Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDSJ M Hoffman, R E Coleman
Cancer Treatment Reviews|January 1, 1993
Osteoclast inhibition for the treatment of bone metastasesR E Coleman, O P Purohit
Seminars in Nuclear Medicine|November 4, 1998
Applications of PET in lung cancerA Al-Sugair, R E Coleman
Pageof 59